ID   PLEC_MOUSE              Reviewed;        4691 AA.
AC   Q9QXS1; E9QN87; Q6S384; Q6S389; Q6S394; Q9CS65; Q9QUT2; Q9QXQ8; Q9QXQ9;
AC   Q9QXR0; Q9QXR1; Q9QXR2; Q9QXR3; Q9QXR4; Q9QXR5; Q9QXR6; Q9QXR7; Q9QXR8;
AC   Q9QXR9; Q9QXS0; Q9QXS2; Q9QXS3;
DT   01-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-APR-2014, sequence version 3.
DT   02-DEC-2020, entry version 195.
DE   RecName: Full=Plectin;
DE            Short=PCN;
DE            Short=PLTN;
DE   AltName: Full=Plectin-1;
DE   AltName: Full=Plectin-6;
GN   Name=Plec; Synonyms=Plec1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ALTERNATIVE SPLICING.
RX   PubMed=14672974; DOI=10.1101/gr.1225204;
RA   Zhang T., Haws P., Wu Q.;
RT   "Multiple variable first exons: a mechanism for cell- and tissue-specific
RT   gene regulation.";
RL   Genome Res. 14:79-89(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-964, ALTERNATIVE SPLICING, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain, Embryo, Heart, Kidney, Skeletal muscle, and Testis;
RX   PubMed=10556294; DOI=10.1093/hmg/8.13.2461;
RA   Fuchs P., Zoerer M., Rezniczek G.A., Spazierer D., Oehler S.,
RA   Castanon M.J., Hauptmann R., Wiche G.;
RT   "Unusual 5' transcript complexity of plectin isoforms: novel tissue-
RT   specific exons modulate actin binding activity.";
RL   Hum. Mol. Genet. 8:2461-2472(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 181-812.
RC   STRAIN=C57BL/6J; TISSUE=Embryo;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5]
RP   PROTEIN SEQUENCE OF 629-633, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   STRAIN=OF1; TISSUE=Hippocampus;
RA   Lubec G., Sunyer B., Chen W.-Q.;
RL   Submitted (JAN-2009) to UniProtKB.
RN   [6]
RP   INTERACTION WITH FER.
RX   PubMed=12200133; DOI=10.1016/s0006-291x(02)02007-7;
RA   Lunter P.C., Wiche G.;
RT   "Direct binding of plectin to Fer kinase and negative regulation of its
RT   catalytic activity.";
RL   Biochem. Biophys. Res. Commun. 296:904-910(2002).
RN   [7]
RP   INTERACTION WITH SYNE3.
RX   PubMed=16330710; DOI=10.1083/jcb.200506083;
RA   Wilhelmsen K., Litjens S.H.M., Kuikman I., Tshimbalanga N., Janssen H.,
RA   van den Bout I., Raymond K., Sonnenberg A.;
RT   "Nesprin-3, a novel outer nuclear membrane protein, associates with the
RT   cytoskeletal linker protein plectin.";
RL   J. Cell Biol. 171:799-810(2005).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-728, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-2788; TYR-3040; TYR-3369;
RP   TYR-3797 AND TYR-4622, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-26
RP   (ISOFORM PLEC-1A), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Mast cell;
RX   PubMed=17947660; DOI=10.4049/jimmunol.179.9.5864;
RA   Cao L., Yu K., Banh C., Nguyen V., Ritz A., Raphael B.J., Kawakami Y.,
RA   Kawakami T., Salomon A.R.;
RT   "Quantitative time-resolved phosphoproteomic analysis of mast cell
RT   signaling.";
RL   J. Immunol. 179:5864-5876(2007).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain cortex;
RX   PubMed=17114649; DOI=10.1074/mcp.m600046-mcp200;
RA   Munton R.P., Tweedie-Cullen R., Livingstone-Zatchej M., Weinandy F.,
RA   Waidelich M., Longo D., Gehrig P., Potthast F., Rutishauser D., Gerrits B.,
RA   Panse C., Schlapbach R., Mansuy I.M.;
RT   "Qualitative and quantitative analyses of protein phosphorylation in naive
RT   and stimulated mouse synaptosomal preparations.";
RL   Mol. Cell. Proteomics 6:283-293(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-823, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17208939; DOI=10.1074/mcp.m600218-mcp200;
RA   Lee J., Xu Y., Chen Y., Sprung R., Kim S.C., Xie S., Zhao Y.;
RT   "Mitochondrial phosphoproteome revealed by an improved IMAC method and
RT   MS/MS/MS.";
RL   Mol. Cell. Proteomics 6:669-676(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4633, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=17242355; DOI=10.1073/pnas.0609836104;
RA   Villen J., Beausoleil S.A., Gerber S.A., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of mouse liver.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:1488-1493(2007).
RN   [14]
RP   INTERACTION WITH TOR1A.
RX   PubMed=18827015; DOI=10.1242/jcs.029454;
RA   Nery F.C., Zeng J., Niland B.P., Hewett J., Farley J., Irimia D., Li Y.,
RA   Wiche G., Sonnenberg A., Breakefield X.O.;
RT   "TorsinA binds the KASH domain of nesprins and participates in linkage
RT   between nuclear envelope and cytoskeleton.";
RL   J. Cell Sci. 121:3476-3486(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18630941; DOI=10.1021/pr800223m;
RA   Zhou H., Ye M., Dong J., Han G., Jiang X., Wu R., Zou H.;
RT   "Specific phosphopeptide enrichment with immobilized titanium ion affinity
RT   chromatography adsorbent for phosphoproteome analysis.";
RL   J. Proteome Res. 7:3957-3967(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4393 AND SER-4396,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 (ISOFORM PLEC-1A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19144319; DOI=10.1016/j.immuni.2008.11.006;
RA   Trost M., English L., Lemieux S., Courcelles M., Desjardins M.,
RA   Thibault P.;
RT   "The phagosomal proteome in interferon-gamma-activated macrophages.";
RL   Immunity 30:143-154(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-4389 AND SER-4393,
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 (ISOFORM PLEC-1A), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=19131326; DOI=10.1074/mcp.m800451-mcp200;
RA   Sweet S.M., Bailey C.M., Cunningham D.L., Heath J.K., Cooper H.J.;
RT   "Large scale localization of protein phosphorylation by use of electron
RT   capture dissociation mass spectrometry.";
RL   Mol. Cell. Proteomics 8:904-912(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-728; SER-1055; THR-4037;
RP   SER-4389; SER-4391; SER-4392; SER-4393; SER-4396; SER-4620; SER-4625;
RP   SER-4629; THR-4630; SER-4633 AND SER-4649, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-21 (ISOFORM PLEC-1A), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Brown adipose tissue, Heart, Kidney, Liver, Lung, Pancreas,
RC   Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [19]
RP   INTERACTION WITH DST.
RX   PubMed=19932097; DOI=10.1016/j.yexcr.2009.11.010;
RA   Steiner-Champliaud M.F., Schneider Y., Favre B., Paulhe F.,
RA   Praetzel-Wunder S., Faulkner G., Konieczny P., Raith M., Wiche G.,
RA   Adebola A., Liem R.K., Langbein L., Sonnenberg A., Fontao L., Borradori L.;
RT   "BPAG1 isoform-b: complex distribution pattern in striated and heart muscle
RT   and association with plectin and alpha-actinin.";
RL   Exp. Cell Res. 316:297-313(2010).
RN   [20]
RP   TISSUE SPECIFICITY, AND IDENTIFICATION IN A COMPLEX WITH EZR; AHNAK; BFSP1;
RP   BFSP2; ANK2; PRX; VIM AND SPECTRIN.
RX   PubMed=21745462; DOI=10.1016/j.ydbio.2011.06.036;
RA   Maddala R., Skiba N.P., Lalane R. III, Sherman D.L., Brophy P.J., Rao P.V.;
RT   "Periaxin is required for hexagonal geometry and membrane organization of
RT   mature lens fibers.";
RL   Dev. Biol. 357:179-190(2011).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1733; LYS-2644 AND LYS-3060, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic fibroblast;
RX   PubMed=23806337; DOI=10.1016/j.molcel.2013.06.001;
RA   Park J., Chen Y., Tishkoff D.X., Peng C., Tan M., Dai L., Xie Z., Zhang Y.,
RA   Zwaans B.M., Skinner M.E., Lombard D.B., Zhao Y.;
RT   "SIRT5-mediated lysine desuccinylation impacts diverse metabolic
RT   pathways.";
RL   Mol. Cell 50:919-930(2013).
RN   [22]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-4634 AND ARG-4647, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [23]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 181-417, AND INTERACTION WITH
RP   VIM.
RX   PubMed=15128297; DOI=10.1111/j.1432-1033.2004.04095.x;
RA   Sevcik J., Urbanikova L., Kost'an J., Janda L., Wiche G.;
RT   "Actin-binding domain of mouse plectin. Crystal structure and binding to
RT   vimentin.";
RL   Eur. J. Biochem. 271:1873-1884(2004).
CC   -!- FUNCTION: Interlinks intermediate filaments with microtubules and
CC       microfilaments and anchors intermediate filaments to desmosomes or
CC       hemidesmosomes. May be involved not only in the cross-linking and
CC       stabilization of cytoskeletal intermediate filaments network, but also
CC       in the regulation of their dynamics.
CC   -!- SUBUNIT: Homodimer or homotetramer (By similarity). Interacts (via
CC       actin-binding domain) with SYNE3 (PubMed:16330710). Interacts (via
CC       calponin-homology (CH) 1 domain) with VIM (via rod region)
CC       (PubMed:15128297). Interacts (via N-terminus) with DST isoform 2 (via
CC       N-terminus) (PubMed:19932097). Interacts with FER (PubMed:12200133).
CC       Interacts with TOR1A (PubMed:18827015). Interacts with ANK3 (By
CC       similarity). Identified in complexes that contain VIM, EZR, AHNAK,
CC       BFSP1, BFSP2, ANK2, PLEC, PRX and spectrin (PubMed:21745462).
CC       {ECO:0000250, ECO:0000250|UniProtKB:P30427,
CC       ECO:0000269|PubMed:12200133, ECO:0000269|PubMed:15128297,
CC       ECO:0000269|PubMed:16330710, ECO:0000269|PubMed:18827015,
CC       ECO:0000269|PubMed:19932097, ECO:0000269|PubMed:21745462}.
CC   -!- INTERACTION:
CC       Q9QXS1; Q9D2G2: Dlst; NbExp=2; IntAct=EBI-774583, EBI-773210;
CC       Q9QXS1; P35486: Pdha1; NbExp=2; IntAct=EBI-774583, EBI-773613;
CC       Q9QXS1-3; P0DP25: CALM3; Xeno; NbExp=11; IntAct=EBI-16145475, EBI-397435;
CC       Q9QXS1-3; P16144: ITGB4; Xeno; NbExp=4; IntAct=EBI-16145475, EBI-948678;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton. Cell junction,
CC       hemidesmosome {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=16;
CC       Name=PLEC-1,2A;
CC         IsoId=Q9QXS1-1; Sequence=Displayed;
CC       Name=PLEC-1;
CC         IsoId=Q9QXS1-2; Sequence=VSP_005048;
CC       Name=PLEC-1A;
CC         IsoId=Q9QXS1-3; Sequence=VSP_005036, VSP_005045, VSP_005048;
CC       Name=PLEC-1B,2A;
CC         IsoId=Q9QXS1-4; Sequence=VSP_005037, VSP_005045;
CC       Name=PLEC-1B;
CC         IsoId=Q9QXS1-5; Sequence=VSP_005037, VSP_005045, VSP_005048;
CC       Name=PLEC-0,1C;
CC         IsoId=Q9QXS1-6; Sequence=VSP_005039, VSP_005047, VSP_005048;
CC       Name=PLEC-0,1C,2A;
CC         IsoId=Q9QXS1-7; Sequence=VSP_005039, VSP_005047;
CC       Name=PLEC-0,1C,2A,3A;
CC         IsoId=Q9QXS1-8; Sequence=VSP_005039, VSP_005047, VSP_005049;
CC       Name=PLEC-1D,2A;
CC         IsoId=Q9QXS1-9; Sequence=VSP_005032, VSP_005041;
CC       Name=PLEC-1D;
CC         IsoId=Q9QXS1-10; Sequence=VSP_005032, VSP_005041, VSP_005048;
CC       Name=PLEC-1E,2A;
CC         IsoId=Q9QXS1-11; Sequence=VSP_005033, VSP_005042;
CC       Name=PLEC-1E;
CC         IsoId=Q9QXS1-12; Sequence=VSP_005033, VSP_005042, VSP_005048;
CC       Name=PLEC-1F;
CC         IsoId=Q9QXS1-13; Sequence=VSP_005034, VSP_005043, VSP_005048;
CC       Name=PLEC-1G;
CC         IsoId=Q9QXS1-14; Sequence=VSP_005038, VSP_005046, VSP_005048;
CC       Name=PLEC-1H;
CC         IsoId=Q9QXS1-15; Sequence=VSP_005040;
CC       Name=PLEC-1I;
CC         IsoId=Q9QXS1-16; Sequence=VSP_005035, VSP_005044;
CC   -!- TISSUE SPECIFICITY: Detected in eye lens fiber cells (at protein level)
CC       (PubMed:21745462). Expressed at high levels in lung, brain, small
CC       intestine, muscle, heart and skin with lower levels found in kidney,
CC       liver, uterus, spleen and salivary gland (PubMed:10556294).
CC       {ECO:0000269|PubMed:10556294, ECO:0000269|PubMed:21745462}.
CC   -!- DOMAIN: The N-terminus interacts with actin, the C-terminus with
CC       vimentin, desmin, GFAP, cytokeratins, lamin B; whereas both the N- and
CC       the C-terminus can bind integrin beta-4.
CC   -!- PTM: Phosphorylated by CDK1; regulates dissociation from intermediate
CC       filaments during mitosis. Isoform PLEC-1A is phosphorylated on Ser-21.
CC       Isoform PLEC-1A is phosphorylated on Tyr-26.
CC   -!- SIMILARITY: Belongs to the plakin or cytolinker family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY480033; AAR95666.1; -; mRNA.
DR   EMBL; AY480038; AAR95671.1; -; mRNA.
DR   EMBL; AY480043; AAR95676.1; -; mRNA.
DR   EMBL; AC110211; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF188006; AAF18066.1; -; mRNA.
DR   EMBL; AF188007; AAF18067.1; -; mRNA.
DR   EMBL; AF188008; AAF18068.1; -; mRNA.
DR   EMBL; AF188009; AAF18069.1; -; mRNA.
DR   EMBL; AF188010; AAF18070.1; -; mRNA.
DR   EMBL; AF188011; AAF18071.1; -; mRNA.
DR   EMBL; AF188012; AAF18072.1; -; mRNA.
DR   EMBL; AF188013; AAF18073.1; -; mRNA.
DR   EMBL; AF188014; AAF18074.1; -; mRNA.
DR   EMBL; AF188015; AAF18075.1; -; mRNA.
DR   EMBL; AF188016; AAF18076.1; -; mRNA.
DR   EMBL; AF188017; AAF18077.1; -; mRNA.
DR   EMBL; AF188018; AAF18078.1; -; mRNA.
DR   EMBL; AF188019; AAF18079.1; -; mRNA.
DR   EMBL; AF188020; AAF18080.1; -; mRNA.
DR   EMBL; AF188021; AAF18081.1; -; mRNA.
DR   EMBL; AF188022; AAF18082.1; -; mRNA.
DR   EMBL; AF188023; AAF18083.1; -; mRNA.
DR   EMBL; AK017743; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS37113.1; -. [Q9QXS1-13]
DR   CCDS; CCDS37114.1; -. [Q9QXS1-2]
DR   CCDS; CCDS37115.1; -. [Q9QXS1-14]
DR   CCDS; CCDS37116.1; -. [Q9QXS1-3]
DR   CCDS; CCDS49644.1; -. [Q9QXS1-5]
DR   CCDS; CCDS49645.1; -. [Q9QXS1-4]
DR   CCDS; CCDS49646.1; -. [Q9QXS1-10]
DR   CCDS; CCDS49647.1; -. [Q9QXS1-1]
DR   CCDS; CCDS49648.1; -. [Q9QXS1-12]
DR   CCDS; CCDS49649.1; -. [Q9QXS1-8]
DR   PIR; D59404; D59404.
DR   RefSeq; NP_001157012.1; NM_001163540.1. [Q9QXS1-1]
DR   RefSeq; NP_001157014.1; NM_001163542.1. [Q9QXS1-8]
DR   RefSeq; NP_001157021.1; NM_001163549.1. [Q9QXS1-4]
DR   RefSeq; NP_001157675.1; NM_001164203.1.
DR   RefSeq; NP_035247.2; NM_011117.2. [Q9QXS1-6]
DR   RefSeq; NP_958791.2; NM_201389.2. [Q9QXS1-2]
DR   RefSeq; NP_958796.2; NM_201394.2. [Q9QXS1-3]
DR   PDB; 1SH5; X-ray; 2.00 A; A/B=181-417.
DR   PDB; 1SH6; X-ray; 2.00 A; A=181-417.
DR   PDB; 4Q57; X-ray; 1.80 A; B=181-411.
DR   PDBsum; 1SH5; -.
DR   PDBsum; 1SH6; -.
DR   PDBsum; 4Q57; -.
DR   SMR; Q9QXS1; -.
DR   BioGRID; 202243; 24.
DR   CORUM; Q9QXS1; -.
DR   DIP; DIP-32004N; -.
DR   IntAct; Q9QXS1; 16.
DR   MINT; Q9QXS1; -.
DR   STRING; 10090.ENSMUSP00000075772; -.
DR   iPTMnet; Q9QXS1; -.
DR   PhosphoSitePlus; Q9QXS1; -.
DR   SwissPalm; Q9QXS1; -.
DR   jPOST; Q9QXS1; -.
DR   PaxDb; Q9QXS1; -.
DR   PeptideAtlas; Q9QXS1; -.
DR   PRIDE; Q9QXS1; -.
DR   Antibodypedia; 3549; 191 antibodies.
DR   Ensembl; ENSMUST00000023226; ENSMUSP00000023226; ENSMUSG00000022565. [Q9QXS1-3]
DR   Ensembl; ENSMUST00000054449; ENSMUSP00000057158; ENSMUSG00000022565. [Q9QXS1-4]
DR   Ensembl; ENSMUST00000071869; ENSMUSP00000071765; ENSMUSG00000022565. [Q9QXS1-12]
DR   Ensembl; ENSMUST00000072692; ENSMUSP00000072478; ENSMUSG00000022565. [Q9QXS1-14]
DR   Ensembl; ENSMUST00000073418; ENSMUSP00000073124; ENSMUSG00000022565. [Q9QXS1-1]
DR   Ensembl; ENSMUST00000074834; ENSMUSP00000074383; ENSMUSG00000022565. [Q9QXS1-13]
DR   Ensembl; ENSMUST00000076442; ENSMUSP00000075772; ENSMUSG00000022565. [Q9QXS1-2]
DR   Ensembl; ENSMUST00000089610; ENSMUSP00000087037; ENSMUSG00000022565. [Q9QXS1-8]
DR   Ensembl; ENSMUST00000169108; ENSMUSP00000126068; ENSMUSG00000022565. [Q9QXS1-10]
DR   Ensembl; ENSMUST00000169714; ENSMUSP00000126526; ENSMUSG00000022565. [Q9QXS1-5]
DR   GeneID; 18810; -.
DR   KEGG; mmu:18810; -.
DR   UCSC; uc007wir.2; mouse. [Q9QXS1-3]
DR   UCSC; uc007wis.2; mouse. [Q9QXS1-14]
DR   UCSC; uc007wit.2; mouse. [Q9QXS1-1]
DR   UCSC; uc007wiu.2; mouse. [Q9QXS1-5]
DR   UCSC; uc007wiv.2; mouse. [Q9QXS1-10]
DR   UCSC; uc007wiw.2; mouse. [Q9QXS1-2]
DR   UCSC; uc007wiz.2; mouse. [Q9QXS1-12]
DR   UCSC; uc007wja.2; mouse. [Q9QXS1-13]
DR   UCSC; uc007wjb.2; mouse. [Q9QXS1-6]
DR   UCSC; uc007wjd.2; mouse. [Q9QXS1-4]
DR   UCSC; uc011zuq.1; mouse. [Q9QXS1-8]
DR   CTD; 5339; -.
DR   MGI; MGI:1277961; Plec.
DR   eggNOG; KOG0516; Eukaryota.
DR   eggNOG; KOG3344; Eukaryota.
DR   GeneTree; ENSGT00940000159045; -.
DR   HOGENOM; CLU_000132_0_0_1; -.
DR   InParanoid; Q9QXS1; -.
DR   OrthoDB; 2464at2759; -.
DR   Reactome; R-MMU-2022090; Assembly of collagen fibrils and other multimeric structures.
DR   Reactome; R-MMU-264870; Caspase-mediated cleavage of cytoskeletal proteins.
DR   Reactome; R-MMU-446107; Type I hemidesmosome assembly.
DR   BioGRID-ORCS; 18810; 4 hits in 19 CRISPR screens.
DR   ChiTaRS; Plec; mouse.
DR   EvolutionaryTrace; Q9QXS1; -.
DR   PRO; PR:Q9QXS1; -.
DR   Proteomes; UP000000589; Chromosome 15.
DR   RNAct; Q9QXS1; protein.
DR   Bgee; ENSMUSG00000022565; Expressed in skeletal muscle tissue and 292 other tissues.
DR   ExpressionAtlas; Q9QXS1; baseline and differential.
DR   Genevisible; Q9QXS1; MM.
DR   GO; GO:0016324; C:apical plasma membrane; ISO:MGI.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:MGI.
DR   GO; GO:0005903; C:brush border; IDA:UniProtKB.
DR   GO; GO:0043292; C:contractile fiber; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0005925; C:focal adhesion; ISO:MGI.
DR   GO; GO:0030056; C:hemidesmosome; ISS:UniProtKB.
DR   GO; GO:0045111; C:intermediate filament cytoskeleton; ISO:MGI.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; ISO:MGI.
DR   GO; GO:0042383; C:sarcolemma; ISS:UniProtKB.
DR   GO; GO:0016528; C:sarcoplasm; ISO:MGI.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0030506; F:ankyrin binding; ISO:MGI.
DR   GO; GO:0008092; F:cytoskeletal protein binding; ISO:MGI.
DR   GO; GO:0047485; F:protein N-terminus binding; ISO:MGI.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; ISO:MGI.
DR   GO; GO:0008307; F:structural constituent of muscle; ISO:MGI.
DR   GO; GO:0005198; F:structural molecule activity; IBA:GO_Central.
DR   GO; GO:0031581; P:hemidesmosome assembly; ISS:UniProtKB.
DR   GO; GO:0045104; P:intermediate filament cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0007584; P:response to nutrient; ISO:MGI.
DR   GO; GO:0042060; P:wound healing; IBA:GO_Central.
DR   CDD; cd00014; CH; 2.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.418.10; -; 2.
DR   Gene3D; 3.90.1290.10; -; 6.
DR   InterPro; IPR001589; Actinin_actin-bd_CS.
DR   InterPro; IPR001715; CH-domain.
DR   InterPro; IPR036872; CH_dom_sf.
DR   InterPro; IPR041615; Desmoplakin_SH3.
DR   InterPro; IPR041573; Desmoplakin_Spectrin-like.
DR   InterPro; IPR043197; Plakin.
DR   InterPro; IPR035915; Plakin_repeat_sf.
DR   InterPro; IPR030269; Plectin.
DR   InterPro; IPR001101; Plectin_repeat.
DR   InterPro; IPR005326; S10_plectin_N.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR018159; Spectrin/alpha-actinin.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   PANTHER; PTHR23169; PTHR23169; 3.
DR   PANTHER; PTHR23169:SF20; PTHR23169:SF20; 3.
DR   Pfam; PF00307; CH; 2.
DR   Pfam; PF00681; Plectin; 18.
DR   Pfam; PF03501; S10_plectin; 1.
DR   Pfam; PF17902; SH3_10; 1.
DR   Pfam; PF18373; Spectrin_like; 1.
DR   SMART; SM00033; CH; 2.
DR   SMART; SM00250; PLEC; 35.
DR   SMART; SM00150; SPEC; 6.
DR   SUPFAM; SSF47576; SSF47576; 1.
DR   SUPFAM; SSF75399; SSF75399; 7.
DR   PROSITE; PS00019; ACTININ_1; 1.
DR   PROSITE; PS00020; ACTININ_2; 1.
DR   PROSITE; PS50021; CH; 2.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Cell junction; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Methylation; Phosphoprotein; Reference proteome;
KW   Repeat; SH3 domain.
FT   CHAIN           1..4691
FT                   /note="Plectin"
FT                   /id="PRO_0000078136"
FT   DOMAIN          185..293
FT                   /note="Calponin-homology (CH) 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   DOMAIN          306..411
FT                   /note="Calponin-homology (CH) 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00044"
FT   REPEAT          653..727
FT                   /note="Spectrin 1"
FT   REPEAT          748..832
FT                   /note="Spectrin 2"
FT   REPEAT          845..938
FT                   /note="Spectrin 3"
FT   DOMAIN          949..1006
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REPEAT          1323..1423
FT                   /note="Spectrin 4"
FT   REPEAT          2795..2832
FT                   /note="Plectin 1"
FT   REPEAT          2833..2870
FT                   /note="Plectin 2"
FT   REPEAT          2871..2908
FT                   /note="Plectin 3"
FT   REPEAT          2909..2946
FT                   /note="Plectin 4"
FT   REPEAT          2947..2984
FT                   /note="Plectin 5"
FT   REPEAT          2988..3022
FT                   /note="Plectin 6"
FT   REPEAT          3123..3160
FT                   /note="Plectin 7"
FT   REPEAT          3161..3198
FT                   /note="Plectin 8"
FT   REPEAT          3199..3236
FT                   /note="Plectin 9"
FT   REPEAT          3237..3274
FT                   /note="Plectin 10"
FT   REPEAT          3275..3312
FT                   /note="Plectin 11"
FT   REPEAT          3315..3350
FT                   /note="Plectin 12"
FT   REPEAT          3492..3529
FT                   /note="Plectin 13"
FT   REPEAT          3530..3567
FT                   /note="Plectin 14"
FT   REPEAT          3568..3605
FT                   /note="Plectin 15"
FT   REPEAT          3606..3643
FT                   /note="Plectin 16"
FT   REPEAT          3647..3681
FT                   /note="Plectin 17"
FT   REPEAT          3827..3864
FT                   /note="Plectin 18"
FT   REPEAT          3865..3902
FT                   /note="Plectin 19"
FT   REPEAT          3903..3940
FT                   /note="Plectin 20"
FT   REPEAT          3941..3978
FT                   /note="Plectin 21"
FT   REPEAT          3982..4015
FT                   /note="Plectin 22"
FT   REPEAT          4070..4107
FT                   /note="Plectin 23"
FT   REPEAT          4108..4145
FT                   /note="Plectin 24"
FT   REPEAT          4146..4183
FT                   /note="Plectin 25"
FT   REPEAT          4184..4221
FT                   /note="Plectin 26"
FT   REPEAT          4225..4259
FT                   /note="Plectin 27"
FT   REPEAT          4272..4312
FT                   /note="Plectin 28"
FT   REPEAT          4415..4452
FT                   /note="Plectin 29"
FT   REPEAT          4453..4490
FT                   /note="Plectin 30"
FT   REPEAT          4491..4528
FT                   /note="Plectin 31"
FT   REPEAT          4529..4566
FT                   /note="Plectin 32"
FT   REPEAT          4567..4604
FT                   /note="Plectin 33"
FT   REGION          1..1478
FT                   /note="Globular 1"
FT                   /evidence="ECO:0000250"
FT   REGION          181..411
FT                   /note="Actin-binding"
FT   REGION          1479..2762
FT                   /note="Central fibrous rod domain"
FT                   /evidence="ECO:0000250"
FT   REGION          2763..4691
FT                   /note="Globular 2"
FT                   /evidence="ECO:0000250"
FT   REGION          4257..4307
FT                   /note="Binding to intermediate filaments"
FT                   /evidence="ECO:0000250"
FT   REGION          4632..4647
FT                   /note="4 X 4 AA tandem repeats of G-S-R-X"
FT   COILED          1477..1697
FT                   /evidence="ECO:0000255"
FT   COILED          1729..2764
FT                   /evidence="ECO:0000255"
FT   MOD_RES         728
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16452087,
FT                   ECO:0000244|PubMed:21183079"
FT   MOD_RES         823
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:17208939"
FT   MOD_RES         1055
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         1443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         1729
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         1733
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:23806337"
FT   MOD_RES         2639
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         2644
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:23806337"
FT   MOD_RES         2781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30427"
FT   MOD_RES         2788
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
FT   MOD_RES         2809
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         2893
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3040
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
FT   MOD_RES         3060
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:23806337"
FT   MOD_RES         3098
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3369
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
FT   MOD_RES         3427
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3792
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         3797
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
FT   MOD_RES         4037
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4061
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19131326,
FT                   ECO:0000244|PubMed:21183079"
FT   MOD_RES         4391
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4392
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19131326,
FT                   ECO:0000244|PubMed:19144319, ECO:0000244|PubMed:21183079"
FT   MOD_RES         4396
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19144319,
FT                   ECO:0000244|PubMed:21183079"
FT   MOD_RES         4397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4398
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4400
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4403
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P30427"
FT   MOD_RES         4418
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4546
FT                   /note="Phosphothreonine; by CDK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JI55"
FT   MOD_RES         4614
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4620
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4622
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
FT   MOD_RES         4623
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   MOD_RES         4625
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4629
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4630
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4633
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17242355,
FT                   ECO:0000244|PubMed:21183079"
FT   MOD_RES         4634
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         4647
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         4649
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21183079"
FT   MOD_RES         4682
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q15149"
FT   VAR_SEQ         1..242
FT                   /note="Missing (in isoform PLEC-1H)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005040"
FT   VAR_SEQ         1..66
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVTNLQVMRAM
FT                   ASLKARGLVRETFA -> MSGEDSEVRPVAVAEGSSNGSSGSPSPGDTLPWNLGKTQRS
FT                   RRSGGGSVGNGSVLDPAERAVIRIA (in isoform PLEC-0,1C, isoform
FT                   PLEC-0,1C,2A,3A and isoform PLEC-0,1C,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005039"
FT   VAR_SEQ         1..44
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAKKDRRPRSLHPHVPGVT -> MAGT
FT                   WAAKGVFTSQREVLLERPCWLDGGCEQVRRGYLYGQLCCV (in isoform PLEC-
FT                   1G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005038"
FT   VAR_SEQ         1..37
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAKKDRRPRSLH -> MSQHRLRVPEP
FT                   EGLGSKRTSSEDNLYLAVLRASEGKK (in isoform PLEC-1A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005036"
FT   VAR_SEQ         1..37
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAKKDRRPRSLH -> MEPSGSLFPSL
FT                   VVVGHVVTLAAVWHWRKGHRQAKDEQ (in isoform PLEC-1B and isoform
FT                   PLEC-1B,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005037"
FT   VAR_SEQ         1..33
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAKKDRRP -> MNETVCRRKLSPSGS
FT                   TNTLSRLRGTSVTCTKTS (in isoform PLEC-1I)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005035"
FT   VAR_SEQ         1..28
FT                   /note="MVAGMLMPLDRLRAIYEVLFREGVMVAK -> MAHLLTSGPPPDEQDFIQAY
FT                   EEVREKYK (in isoform PLEC-1F)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005034"
FT   VAR_SEQ         1..15
FT                   /note="MVAGMLMPLDRLRAI -> MDPSRAIQHEISSLK (in isoform PLEC-
FT                   1E and isoform PLEC-1E,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005033"
FT   VAR_SEQ         1..5
FT                   /note="MVAGM -> MKIVP (in isoform PLEC-1D and isoform PLEC-
FT                   1D,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005032"
FT   VAR_SEQ         6..180
FT                   /note="Missing (in isoform PLEC-1D and isoform PLEC-1D,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005041"
FT   VAR_SEQ         16..180
FT                   /note="Missing (in isoform PLEC-1E and isoform PLEC-1E,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005042"
FT   VAR_SEQ         29..180
FT                   /note="Missing (in isoform PLEC-1F)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005043"
FT   VAR_SEQ         34..180
FT                   /note="Missing (in isoform PLEC-1I)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005044"
FT   VAR_SEQ         38..180
FT                   /note="Missing (in isoform PLEC-1A, isoform PLEC-1B and
FT                   isoform PLEC-1B,2A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005045"
FT   VAR_SEQ         45..180
FT                   /note="Missing (in isoform PLEC-1G)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005046"
FT   VAR_SEQ         67..180
FT                   /note="Missing (in isoform PLEC-0,1C, isoform PLEC-0,1C,2A
FT                   and isoform PLEC-0,1C,2A,3A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005047"
FT   VAR_SEQ         202..206
FT                   /note="Missing (in isoform PLEC-1, isoform PLEC-1A, isoform
FT                   PLEC-1B, isoform PLEC-1D, isoform PLEC-1E, isoform PLEC-1G,
FT                   isoform PLEC-1F and isoform PLEC-0,1C)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005048"
FT   VAR_SEQ         239
FT                   /note="E -> ERDVIRSVRLPRE (in isoform PLEC-0,1C,2A,3A)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005049"
FT   CONFLICT        2535
FT                   /note="A -> V (in Ref. 1; AAR95666/AAR95671/AAR95676)"
FT                   /evidence="ECO:0000305"
FT   HELIX           181..199
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           205..207
FT                   /evidence="ECO:0000244|PDB:1SH5"
FT   TURN            214..220
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           222..232
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           244..260
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           270..274
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           278..292
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           294..296
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           308..319
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   TURN            320..322
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           333..335
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           339..348
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           350..352
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           355..360
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           363..378
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           386..389
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   STRAND          390..393
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   HELIX           396..408
FT                   /evidence="ECO:0000244|PDB:4Q57"
FT   MOD_RES         Q9QXS1-3:21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19131326,
FT                   ECO:0000244|PubMed:19144319, ECO:0000244|PubMed:21183079"
FT   MOD_RES         Q9QXS1-3:26
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:17947660"
SQ   SEQUENCE   4691 AA;  534188 MW;  91A09EC8181137D1 CRC64;
     MVAGMLMPLD RLRAIYEVLF REGVMVAKKD RRPRSLHPHV PGVTNLQVMR AMASLKARGL
     VRETFAWCHF YWYLTNEGID HLRQYLHLPP EIVPASLQRV RRPVAMVIPA RRRSPHVQTM
     QGPLGCPPKR GPLPAEDPAR EERQVYRRKE REEGAPETPV VSATTVGTLA RPGPEPAPAT
     DERDRVQKKT FTKWVNKHLI KHWRAEAQRH ISDLYEDLRD GHNLISLLEV LSGDSLPREK
     GRMRFHKLQN VQIALDYLRH RQVKLVNIRN DDIADGNPKL TLGLIWTIIL HFQISDIQVS
     GQSEDMTAKE KLLLWSQRMV EGYQGLRCDN FTTSWRDGRL FNAIIHRHKP MLIDMNKVYR
     QTNLENLDQA FSVAERDLGV TRLLDPEDVD VPQPDEKSII TYVSSLYDAM PRVPGAQDGV
     RANELQLRWQ EYRELVLLLL QWIRHHTAAF EERKFPSSFE EIEILWCQFL KFKETELPAK
     EADKNRSKVI YQSLEGAVQA GQLKIPPGYH PLDVEKEWGK LHVAILEREK QLRSEFERLE
     CLQRIVSKLQ MEAGLCEEQL NQADALLQSD IRLLASGKVA QRAGEVERDL DKADGMIRLL
     FNDVQTLKDG RHPQGEQMYR RVYRLHERLV AIRTEYNLRL KAGVGAPVTQ VTLQSTQRRP
     ELEDSTLRYL QDLLAWVEEN QRRIDSAEWG VDLPSVEAQL GSHRGMHQSI EEFRAKIERA
     RNDESQLSPA TRGAYRDCLG RLDLQYAKLL NSSKARLRSL ESLHGFVAAA TKELMWLNEK
     EEEEVGFDWS DRNTNMAAKK ESYSALMREL EMKEKKIKEI QNTGDRLLRE DHPARPTVES
     FQAALQTQWS WMLQLCCCIE AHLKENTAYF QFFSDVREAE EQLQKLQETL RRKYSCDRTI
     TVTRLEDLLQ DAQDEKEQLN EYKGHLSGLA KRAKAIVQLK PRNPAHPVRG HVPLIAVCDY
     KQVEVTVHKG DQCQLVGPAQ PSHWKVLSGS SSEAAVPSVC FLVPPPNQEA QEAVARLEAQ
     HQALVTLWHQ LHVDMKSLLA WQSLSRDIQL IRSWSLVTFR TLKPEEQRQA LRNLELHYQA
     FLRDSQDAGG FGPEDRLVAE REYGSCSRHY QQLLQSLEQG EQEESRCQRC ISELKDIRLQ
     LEACETRTVH RLRLPLDKDP ARECAQRIAE QQKAQAEVEG LGKGVARLSA EAEKVLALPE
     PSPAAPTLRS ELELTLGKLE QVRSLSAIYL EKLKTISLVI RSTQGAEEVL KTHEEQLKEA
     QAVPATLQEL EATKASLKKL RAQAEAQQPV FNTLRDELRG AQEVGERLQQ RHGERDVEVE
     RWRERVTQLL ERWQAVLAQT DVRQRELEQL GRQLRYYRES ADPLSAWLQD AKRRQEQIQA
     VPIANCQAAR EQLRQEKALL EEIERHGEKV EECQKFAKQY INAIKDYELQ LITYKAQLEP
     VASPAKKPKV QSGSESVIQE YVDLRTRYSE LTTLTSQYIK FISETLRRME EEERLAEQQR
     AEERERLAEV EAALEKQRQL AEAHAQAKAQ AELEAQELQR RMQEEVARRE EAAVDAQQQK
     RSIQEELQHL RQSSEAEIQA KAQQVEAAER SRMRIEEEIR VVRLQLETTE RQRGGAEGEL
     QALRARAEEA EAQKRQAQEE AERLRRQVQD ESQRKRQAEA ELALRVKAEA EAAREKQRAL
     QALDELRLQA EEAERRLRQA EAERARQVQV ALETAQRSAE VELQSKRASF AEKTAQLERT
     LQEEHVTVAQ LREEAERRAQ QQAEAERARE EAERELERWQ LKANEALRLR LQAEEVAQQK
     SLAQADAEKQ KEEAEREARR RGKAEEQAVR QRELAEQELE KQRQLAEGTA QQRLAAEQEL
     IRLRAETEQG EQQRQLLEEE LARLQHEATA ATQKRQELEA ELAKVRAEME VLLASKARAE
     EESRSTSEKS KQRLEAEAGR FRELAEEAAR LRALAEEAKR QRQLAEEDAA RQRAEAERVL
     TEKLAAISEA TRLKTEAEIA LKEKEAENER LRRLAEDEAF QRRRLEEQAA LHKADIEERL
     AQLRKASESE LERQKGLVED TLRQRRQVEE EIMALKVSFE KAAAGKAELE LELGRIRSNA
     EDTMRSKEQA ELEAARQRQL AAEEEQRRRE AEERVQRSLA AEEEAARQRK VALEEVERLK
     AKVEEARRLR ERAEQESARQ LQLAQEAAQK RLQAEEKAHA FVVQQREEEL QQTLQQEQNM
     LDRLRSEAEA ARRAAEEAEE AREQAEREAA QSRKQVEEAE RLKQSAEEQA QAQAQAQAAA
     EKLRKEAEQE AARRAQAEQA ALKQKQAADA EMEKHKKFAE QTLRQKAQVE QELTTLRLQL
     EETDHQKSIL DEELQRLKAE VTEAARQRSQ VEEELFSVRV QMEELGKLKA RIEAENRALI
     LRDKDNTQRF LEEEAEKMKQ VAEEAARLSV AAQEAARLRQ LAEEDLAQQR ALAEKMLKEK
     MQAVQEATRL KAEAELLQQQ KELAQEQARR LQEDKEQMAQ QLVEETQGFQ RTLEAERQRQ
     LEMSAEAERL KLRMAEMSRA QARAEEDAQR FRKQAEEIGE KLHRTELATQ EKVTLVQTLE
     IQRQQSDHDA ERLREAIAEL EREKEKLKQE AKLLQLKSEE MQTVQQEQIL QETQALQKSF
     LSEKDSLLQR ERFIEQEKAK LEQLFQDEVA KAKQLREEQQ RQQQQMEQEK QELMASMEEA
     RRRQREAEEG VRRKQEELQH LEQQRQQQEK LLAEENQRLR ERLQRLEEEH RAALAHSEIA
     TTQAASTKAL PNGRDAPDGP SVEAEPEYTF EGLRQKVPAQ QLQEAGILSQ EELQRLAQGH
     TTVAELTQRE DVYRYLKGRS SIAGLLLKPT NEKLSVYTAL QRQLLSPGTA LILLEAQAAS
     GFLLDPVRNR RLTVNEAVKE GVVGPELHHK LLSAERAVTG YKDPYTGEQI SLFQAMKKDL
     IVRDHGVRLL EAQIATGGII DPVHSHRVPV DVAYKRGYFD EEMNRILSDP SDDTKGFFDP
     NTHENLTYLQ LLERCVEDPE TGLRLLPLTD KAAKGGELVY TDTEARDVFE KATVSAPFGK
     FQGRTVTIWE IINSEYFTAE QRRDLLQQFR TGHITVEKII KIVITVVEEH ERKGQLCFEG
     LRALVPAAEL LDSGVISHEL YQQLQRGERS VREVAEADSV RQALRGTNVI AGVWLEEAGQ
     KLSIYEALKK DLLQPEVAVA LLEAQAGTGH IIDPATSARL TVDEAVRAGL VGPELHEKLL
     SAEKAVTGYR DPYSGQSVSL FQALKKGLIP REQGLRLLDA QLSTGGIVDP SKSHRVPLDV
     AYARGYLDKE TNRALTSPRD DARVYHDPST QEPVTYSQLQ QRCRSDQLTG LSLLPLSEKA
     VRARQEEVYS ELQARETLEQ AKVEVPVGSF KGRAMTVWEL ISSEYFTEEQ RQELLRQFRT
     GKVTVEKVIK IVITIVEEVE TRRQERLSFS GLRAPVPASE LLDAKILSRA QFDQLKDGKT
     SVKELSEVGS VRTLLQGSGC LAGIYLEDSK EKVTIYEAMR RGLLRPSTAT LLLEAQAATG
     FLVDPVRNQR LYVHEAVKAG VVGPELHEKL LSAEKAVTGY KDPYSGNTIS LFQAMKKGLV
     LRDHAIRLLE AQVATGGIID PVHSHRLPVD VAYQRGYFDE EMNRVLADPS DDTKGFFDPN
     THENLTYLQL LERCVEDPET GLRLLPLKGA EKTEVVETTQ VYTEEETRRA FEETQIDIPG
     GGSHGGSSMS LWEVMQSNMI PEDQRARLMA DFQAGRVTKE RMIIIIIEII EKTEIIRQQN
     LASYDYVRRR LTAEDLYEAR IISLETYNLF REGTKNLREV LEMESAWRYL YGTGAVAGVY
     LPGSRQTLTI YQALKKGLLS AEVARLLLEA QAATGFLLDP VKGERLTVDE AVRKGLVGPE
     LHDRLLSAER AVTGYRDPYT EQTISLFQAM KKELIPAEEA LRLLDAQLAT GGIVDPRLGF
     HLPLEVAYQR GYLNKDTHDQ LSEPSEVRSY VDPSTDERLS YTQLLKRCRR DDPSGQMLLL
     LSDARKLTFR GLRKQITVEE LVRSQVMDEA TALQLQEGLT SIEEVTKNLQ KFLEGTSCIA
     GVFVDATKER LSVYQAMKKG IIRPGTAFEL LEAQAATGYV IDPIKGLKLT VEEAVRMGIV
     GPEFKDKLLS AERAVTGYKD PYSGKLISLF QAMKKGLILK DHGIRLLEAQ IATGGIIDPE
     ESHRLPVEVA YKRGLFDEEM NEILTDPSDD TKGFFDPNTE ENLTYLQLME RCITDPQTGL
     CLLPLKEKKR ERKTSSKSSV RKRRVVIVDP ETGKEMSVYE AYRKGLIDHQ TYLELSEQEC
     EWEEITISSS DGVVKSMIID RRSGRQYDID DAITKNLIDR SALDQYRAGT LSITEFADML
     SGNAGGFRSR SSSVGSSSSY PISSAGPRTQ LASWSDPTEE TGPVAGILDT ETLEKVSITE
     AMHRNLVDNI TGQRLLEAQA CTGGIIDPST GERFPVTEAV NKGLVDKIMV DRINLAQKAF
     CGFEDPRTKT KMSAAQALKK GWLYYEAGQR FLEVQYLTGG LIEPDTPGRV SLDEALQRGT
     VDARTAQKLR DVSAYSKYLT CPKTKLKISY KDALDRSMVE EGTGLRLLEA AAQSSKGYYS
     PYSVSGSGST AGSRTGSRTG SRAGSRRGSF DATGSGFSMT FSSSSYSSSG YGRRYASGPS
     ASLGGPESAV A
//
